Twitter Beğeni Hilesi

⚠️ Spill The Tea: In the next few days, we’ll start burning #SEED of inactive users. If you’ve been away for more than 30 days, hurry back — your $SEED is at risk! 📌 𝐒𝐧𝐞𝐚𝐤 𝐏𝐞𝐞𝐤 𝐨𝐧 𝐒𝐄𝐄𝐃 𝐅𝐮𝐭𝐮𝐫𝐞 𝐏𝐥𝐚𝐧: youtube.com/shorts/UK4gOzx… We’re focused on rewarding our

$AGBA Group announces shareholder approval of all Triller Corp. merger proposals at the Extraordinary General Meeting. With only final Nasdaq approval pending, the merger is on track for completion. More details: agba.com/ir

$AGBA News September 03, 2024 Agba and Triller Announce Amended and Restated Merger Agreement finance.yahoo.com/news/agba-tril…

$CVKD Zacks Small Cap Research September 16, 2024 New Blood Thinner Ready For Phase 3; Initiating Coverage Of Cadrenal Therapeutics, Inc… scr.zacks.com/news/news-deta…

$AGBA - Upon transaction closing, the newly combined companies will trade on the Nasdaq under the name “Triller Group Inc.” with new expected ticker “ILLR” finance.yahoo.com/news/agba-tril…

$CVKD - We are initiating coverage of Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) with a $30.00 valuation. Cadrenal is a biopharmaceutical developing innovative therapies for life-threatening cardiovascular and renal diseases. scr.zacks.com/news/news-deta…

#Nasdaq ~ $AGBA $AGBA $CVKD $OCTO $SOXS $NVDA $STEN $DELL $TMF $SOXL $WMT $LGF.A $CHWY $FIAT $GOOGL $BTG $FFIF $TSLA $UPST $TSLL $AAPL $NVDL AGBA TRILLER TrillerTV Sony Conor McGregor #Triller #Wealth #Insurance #Investment #Securities #Properties #Healthcare

$AGBA - Transaction closing is anticipated to occur soon, subject to regulatory clearance, approval by AGBA’s shareholders and other customary closing conditions finance.yahoo.com/news/agba-tril…

$CVKD - The company’s lead development candidate, tecarfarin, is a late-stage novel oral and reversible anticoagulant intended to prevent heart attacks, stroke, and death due to blood clots in patients suffering from rare cardiovascular conditions. scr.zacks.com/news/news-deta…

#Nasdaq ~ $AGBA $AGBA $CVKD $OCTO $SOXS $NVDA $STEN $DELL $TMF $SOXL $WMT $LGF.A $CHWY $FIAT $GOOGL $BTG $FFIF $TSLA $UPST $TSLL $AAPL $NVDL AGBA TRILLER TrillerTV Sony Conor McGregor #Triller #Wealth #Insurance #Investment #Securities #Properties #Healthcare

$AGBA - Merger will create a cutting-edge, next-generation, social media and entertainment platform for creators and users, powered by AI and machine-learning technologies finance.yahoo.com/news/agba-tril…

$CVKD - Phase 3 Ready Asset – Cadrenal has designed a randomized, single blind, Phase 3, multicenter study to evaluate tecarfarin compared to warfarin in patients with LVADs. The final protocol will be announced following discussions with the FDA. scr.zacks.com/news/news-deta…

#Nasdaq ~ $AGBA $AGBA $CVKD $OCTO $SOXS $NVDA $STEN $DELL $TMF $SOXL $WMT $LGF.A $CHWY $FIAT $GOOGL $BTG $FFIF $TSLA $UPST $TSLL $AAPL $NVDL AGBA TRILLER TrillerTV Sony Conor McGregor #Triller #Wealth #Insurance #Investment #Securities #Properties #Healthcare

$AGBA - Once the Triller Reorganization and the AGBA Domestication have occurred, the combined companies will merge (the “Merger”) and Triller will become a wholly owned subsidiary of AGBA Delaware Parent. finance.yahoo.com/news/agba-tril…

$CVKD - ODD for LVADs and ESKD+AFib – The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to tecarfarin for the prevention of thrombosis in patients with LVADs and ODD and Fast Track status scr.zacks.com/news/news-deta…

#Nasdaq ~ $AGBA $AGBA $CVKD $OCTO $SOXS $NVDA $STEN $DELL $TMF $SOXL $WMT $LGF.A $CHWY $FIAT $GOOGL $BTG $FFIF $TSLA $UPST $TSLL $AAPL $NVDL AGBA TRILLER TrillerTV Sony Conor McGregor #Triller #Wealth #Insurance #Investment #Securities #Properties #Healthcare

$AGBA - AGBA and Triller have agreed that the closing of the Merger (the “Closing”) will occur as soon as possible, subject to regulatory clearance, approval by AGBA’s shareholders and the other closing conditions provided for in the Merger Agreement finance.yahoo.com/news/agba-tril…

$CVKD - Combining the net present value for tecarfarin in those two indications with the current cash ($5 million) and the potential cash from warrant exercises (approximately $9 million) leads to a net present value for Cadrenal of $106 million. scr.zacks.com/news/news-deta…

Stock Investors Daily Video September 17, 2024 Manole Capital Management Discusses $AGBA and Triller Mega Merger on Seeking Alpha youtu.be/ssRIb9v65lw?si…

Stock Investors Daily Video September 17, 2024 Zacks Small Cap Research Initiates Coverage on $CVKD youtu.be/8tYCcSO5j-8?si…